How a No Room Rent Cap Can Improve Your Health Insurance Claim

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

A hospital stay can become expensive for reasons that go beyond treatment alone. Room charges are one part of the bill that may affect how much you eventually pay out of pocket. A health insurance policy with no room rent cap can offer more flexibility in choosing a hospital room, subject to policy terms. This […]

The post How a No Room Rent Cap Can Improve Your Health Insurance Claim appeared first on Medical News Bulletin.

FDA OKs Etcamah for advanced breast cancer

The FDA has granted accelerated approval to camizestrant in combination with a CDK4/6 inhibitor for adults with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer.
The approval for camizestrant (Etcamah, AstraZeneca) is dependent on the detection of an ESR1 mutation during aromatase and CDK4/6 inhibitor therapy.
The FDA said in a press release that it based its decision on the randomized, phase 3 SERENA-6 trial, which showed a 56% improvement in PFS with the camizestrant combination compared with standard of care.
“This is the proof that precision medicine is

Walmart frozen berries recalled for possible E. coli contamination

The FDA announced a recall of frozen berries sold at Walmart due to an expanding Escherichia coli outbreak that has sickened 17 people in two states — six of whom have been hospitalized.
The recalled product — Great Value Organic Triple Berry Blend — has been sold in Walmart stores in 16 states: Alabama, Arkansas, Florida, Illinois, Indiana, Kentucky, Louisiana, Minnesota, Mississippi, Missouri, North Carolina, Ohio, Oklahoma, South Carolina, Texas and Wisconsin.
The product information is as follows:
The recall is part of a broader investigation of frozen berry products sourced from a Chilean

Missed pediatric appointments spiked during ICE activity in Minnesota

Missed appointments and reschedule requests spiked at pediatric outpatient facilities in Minnesota during increased Immigration and Customs Enforcement activity last winter, data show.
Hispanic/Latino and Spanish-speaking families were disproportionately affected, according to findings published in Pediatrics.
“I saw a precipitous drop in my clinic patients during the peak Operation Metro Surge timeframe,” Asitha D. L. Jayawardena, MD, MPH, FACS, a pediatric otolaryngologist at Children’s Minnesota, told Healio. “These were disproportionately Hispanic and Somali families, so I decided to run a

‘Striking’: Menopause inconsistently documented in EHRs

Menopause remains inconsistently documented in electronic health records, according to a new systematic review published in Menopause.
“We expected to find some variation in how menopause was documented, but the extent of the inconsistency was striking,” Robin R. Austin, PhD, DNP, DC, MSN, RN, NI-BC, FAMIA, FAAN, an associate professor at the University of Minnesota School of Nursing, told Healio. “Menopause status and symptoms were often identified indirectly or incompletely, making it difficult to understand where a woman is in the menopause transition.”
According to Austin, more researchers

Physicians publish fall vaccine guidance, filling void left by CDC

Four medical societies have published vaccine recommendations for the 2026-2027 respiratory diseases season, filling a void in guidance at the federal level.
The American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Infectious Diseases Society of America provided recommendations this week for vaccines against COVID-19, influenza and respiratory syncytial virus.
The groups collaborated on their recommendations with the American Medical Association and the Vaccine Integrity Project at the University of Minnesota’s Center

TearCare receives indication to improve meibomian gland function

The FDA cleared an updated label for the TearCare heat therapy system to improve meibomian gland function in evaporative dry eye disease, according to a press release.
“We believe the new indication helps reinforce to clinicians that the use of TearCare helps them raise the bar from simply managing the consequences of MGD toward intervening earlier to address the dysfunctional glands underlying the disease,” Matt Gibson, senior director of marketing, interventional dry eye, at Sight Sciences, told Healio.
According to the company, the update “improves meibomian gland function in adult patients

Alcon launches Unity M ophthalmic microscope

Alcon launched Unity M, a surgical microscope designed to increase surgical precision with advanced visualization features for both anterior and posterior segment surgeons, according to a press release.
“Through our collaboration with eye care professionals, we heard a consistent need for greater control and reliable visualization during surgery,” Sergio Duplan, senior vice president, president, Americas, at Alcon, told Healio. “That’s why we built Unity M specifically for ophthalmology, delivering a stable red reflex, color tunable illumination and optimized depth of field to help surgeons

Pulmonary artery denervation may work for HF-related pulmonary hypertension

MUNICH — Pulmonary artery denervation greatly lowered clinical worsening at 2 years in patients with left-sided pulmonary hypertension and heart failure, researchers reported at the European Society of Cardiology Congress.
The PADN-HF-PH trial, simultaneously published in The New England Journal of Medicine, included 264 patients (median age, 66 years; 51% men) with left-sided pulmonary hypertension and HF regardless of ejection fraction who were randomly assigned to pulmonary artery denervation (PADN system, Pulnovo Medical) plus guideline-directed medical therapy (GDMT) or GDMT alone,

Consensus establishes oral JAKs as first-line treatment for severe alopecia areata

Oral JAK inhibitors are now considered the first-line treatment for adults with severe alopecia areata, with a preference for FDA-approved therapies, according to a Delphi consensus statement published in JAMA Dermatology.
The consensus statement, produced through a partnership with the National Alopecia Areata Foundation and the American Hair Research Society, establishes practical guidelines for treating adults with severe alopecia areata in the U.S., according to Maryanne Makredes Senna, MD, director of the Lahey Hair Loss Center of Excellence at Lahey Clinic and a consensus statement